Evidence map›Paper›PMID 42585408›Full record

SynthesisRevista do Instituto de Medicina Tropical de Sao Paulo2026

HTLV-1-associated diseases: a systematic review.

Rosa Maria Nascimento Marcusso, Víctor Ângelo Folgosi, Augusto César Penalva de Oliveira, Jorge Casseb

Abstract readSystematic Review
In one paragraph

Synthesis in Revista do Instituto de Medicina Tropical de Sao Paulo, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rosa Maria Nascimento MarcussoInstituto de Infectologia Emilio Ribas, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-8396-0263
Víctor Ângelo FolgosiUniversidade de São Paulo, Faculdade de Medicina, Divisão de Dermatologia, Laboratório de Investigação Médica (LIM-56), São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-0114-7587
Augusto César Penalva de OliveiraInstituto de Infectologia Emilio Ribas, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-4084-7973
Jorge CassebUniversidade de São Paulo, Faculdade de Medicina, Divisão de Dermatologia, Laboratório de Investigação Médica (LIM-56), São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-4553-2559

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with a broad spectrum of clinical manifestations. While most people living with HTLV-1 remain asymptomatic, a proportion develops severe conditions such as adult T-cell leukemia/lymphoma or HTLV-1-associated myelopathy/tropical spastic paraparesis. Increasing evidence also indicates that HTLV-1 infection is related to multiple systemic complications involving different organ systems (including neurological, pulmonary, dermatological, rheumatological, and ophthalmological disorders) and opportunistic infections. Given the growing recognition of these diverse manifestations, this review aims to compile and synthesize the scientific evidence regarding clinical manifestations, co-infections, opportunistic diseases, and complications related to HTLV-1 infection.

Indexed as

HTLV-I InfectionsHuman T-lymphotropic virus 1Paraparesis, Tropical SpasticHumans

Identifiers

PMID42585408
PMCPMC13456576

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.